default author photo

Domenica Lo Russo

Catholic University of the Sacred Heart, Rome - Gynecologic Oncology Unit

SCHOLARLY PAPERS

1

DOWNLOADS

126

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

MITO END-3: A Randomized Phase II Trial of Avelumab Plus Carboplatin and Paclitaxel Compared to Carboplatin and Paclitaxel in Advanced or Recurrent Endometrial Cancer

Number of pages: 32 Posted: 27 Dec 2022
Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Uro-Gynecological Medical Oncology, Catholic University of the Sacred Heart, Rome - Gynecologic Oncology Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Uro-Gynecological Medical Oncology, Centro di Riferimento Oncologico - Medical Oncology and Oncological Prevention Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) - Clinical and Experimental Oncology Unit, Azienda Sanitaria Universitaria Friuli Centrale - Oncology Department, “Senatore Antonio Perrino” Hospita - Medical Oncology Unit, Baylor University - Lester and Sue Smith Breast Center, Oncology Unit, “S. Vincenzo” Hospital, S. Maria delle Croci Hospital - Oncology Unit, Infermi Hospital - Medical Oncology Unit, Mater Salutis Hospital AULSS9, “Scaligera” - Medical Oncology Unit, Medical Oncology Unit “Santo Stefano” Hospital, Niguarda Ca' Granda Hospital - Oncology Unit, IRCCS Ospedale Policlinico San Martino - U.O. Clinica di Oncologia Medica, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Uro-Gynecological Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS - Department of Woman, Child and Public Health, Centro di Riferimento Oncologico - Medical Oncology and Oncological Prevention Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) - Clinical and Experimental Oncology Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Uro-Gynecological Medical Oncology, Catholic University of the Sacred Heart, Rome - Gynecologic Oncology Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Pathological Anatomy and Cytopathology Unit, University of Campania “Luigi Vanvitelli” - Medical Statistics and Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit
Downloads 126 (572,948)

Abstract:

Loading...

Endometrial Cancer, First-line treatment, Chemotherapy, Avelumab